Global Biological Safety Testing Products & Services Market Research Report (2021 to 2027) – by Product, Test Type, Application and Region

DUBLIN, January 28, 2022–(BUSINESS WIRE)–The “Biological Safety Testing Products & Services Market Research Report by Product, by Test Type, by Application, by Region – Global Forecast to 2027 – Cumulative Impact of COVID-19” report has been added to’s offering.

The Global Biological Safety Testing Products & Services Market size was estimated at USD 4,152.22 million in 2020, is expected to reach USD 4,593.67 million in 2021, and is projected to grow at a CAGR of 10.99% to reach USD 8,619.41 million by 2027.

Competitive Strategic Window:

The Competitive Strategic Window analyzes the competitive landscape in terms of markets, applications, and geography to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable acquisition fit for the vendors to adopt successive merger and strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix evaluates and categorizes the vendors in the Biological Safety Testing Products & Services Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features , and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:

The Market Share Analysis offers the analysis of vendors noting their contribution to the overall market. It provides the idea of ​​its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of ​​the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

The report provides insights on the following pointers:

1. Market Penetration: Provides comprehensive information on the market offered by the key players

2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets

3. Market Diversification: Provides detailed information about new product launches, unapped geographies, recent developments, and investments

4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players

5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:

1. What is the market size and forecast of the Global Biological Safety Testing Products & Services Market?

2. What are the inhibiting factors and impact of COVID-19 shaping the Global Biological Safety Testing Products & Services Market during the forecast period?

3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Biological Safety Testing Products & Services Market?

4. What is the competitive strategic window for opportunities in the Global Biological Safety Testing Products & Services Market?

5. What are the technology trends and regulatory frameworks in the Global Biological Safety Testing Products & Services Market?

6. What is the market share of the leading vendors in the Global Biological Safety Testing Products & Services Market?

7. What modes and strategic moves are considered suitable for entering the Global Biological Safety Testing Products & Services Market?

Market Dynamics


  • Changing lifestyle increases chronic diseases such as diabetes and cancer

  • Government intervention in adoption of good manufacturing practices during drug development

  • Increasing development and commercialization of drugs




Companies Mentioned

  • Asahi Kasei Medical Co., Ltd.

  • Avance Biosciences

  • BSL Bio service Scientific Laboratories GmbH

  • BSL Bioservice

  • Charles River Laboratories International, Inc.

  • Creative Biogene

  • Cytovance Biologics, Inc.

  • Eurofins Scientific

  • Lonza Group AG

  • Merck KGaA

  • MilliporeSigma

  • Nordic Scientific & Natural Solutions

  • North American Science Associates, Inc.

  • NuAire, Inc.

  • Pace Analytical Services LLC

  • Paragon Bioservices Inc.

  • Promega Corporation

  • Samsung Biologics

  • Sartorius Stedim BioOutsource Limited

  • SGS SA

  • Sigma-Aldrich Corporation

  • Thermo Fisher Scientific, Inc

  • Toxikon Corporation

  • Toyobo Co., Ltd.

  • WuXi Biologics (Cayman), Inc

For more information about this report visit

View source version on

Laura Wood, Senior Press Manager
[email protected]
For EST Office Hours Call 1-917-300-0470
For US/CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Leave a Comment